Week 252 Review - Another dip but a massive trading victory

Most things had a great week, unfortunately OPTI:Optibiotix didn't, so the difference between cost and value widened by £2,966. That increased the deficit to £31,778 and dropped total portfolio value to £83,670.

There was only one big loser this week, but it was OPTI:Optibiotix as mentioned above which dropped 4p and cost me £4,400. Great news that the portfolio only fell by just under £3,000, meaning everything else covered £1,400 of the OPTI losses.

SBTX:SkinBioTherapeutics had a good week, climbing 5% in my ISA and 7% in my SIPP. I thought they would climb higher now the OPTI sale has cleared, but I think investors are scared they will do it again.

TRMR:Tremor went up 6% but I'm still losing 47% in my trading account.

IQE:IQE climbed 5% in my SIPP, 6% in my trading account, and 9% in my ISA as they very slowly but steadily recover.

FXPO:Ferrexpo are one of my new "magic formula" shares and are already in profit, climbing 10% this week to go 6% up altogether and making £59 potential profit. Even better they went ex-dividend on Thursday so I should get around £18 and my SIPP is starting to behave like a proper pension account.

SAE:Simec Atlantis Energy has had a rocket up it lately, and climbed 11% this week. They are still 81% down and it's a very small holding, but I shall watch with interest.

Share of the Week by a million miles is JLP:Jubilee Metals, which is finally starting to re-rate. My ISA holding climbed 11% and is only 18% down now, my new SIPP holding climbed 15% and is 5% in profit, and best of all my trading holding climbed to 30% so I sold them and banked some profit.

Pretty upsetting that despite so many shares climbing this week, we're still heading back towards the orange line.

A worryingly steep drop, but we're on the right side of the trend line.

The ISA and share accounts look like this

			Weekly Change
Cash	£104.45		+£96.47
Portfolio cost	£59,827.79		+£0
Portfolio sell value (bid price-commission)	£41,574.55	(-30.5%)	-£1.698.30
Potential profits	£0		+£0
Yr 5 Dividends	£0.85		+£0.22
Yr 5 Profit from sales	£-167.28		+£0
Yr 5 Average monthly cash profit	-£20.11	(-0.4%)	+£0.09
Total Dividends	£1,343.15		+£0.22
Total Profit from sales	£20,224.13		+£0
Average monthly cash profit	£366.93	(7.4%)	-£1.53
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	11.2%		+0%
Compound performance	54%		+0%

First of all let's cover the 22p dividend. That was the left-over after the share consolidation by IES:Invinity Energy. I also added £100 to my ISA as I'd run out of cash to pay the £3.75 fees, and the minimum to start up a new ISA for the tax year is £100. It means a small increase in the injection amount.

Portfolio value is down £1,698 thanks to OPTI:Optibiotix, and there's still nothing in profit. The nearest shares to being in profit are OPTI:Optibiotix and IKA:Ilika, which are both down by 16%, and JLP:Jubileee Metals which is down by 18%. SBTX:SkinBioTherapeutics is down 25% and everything else is absolutely trashed.

This does raise the rather worrying question of where my next sale is coming from to try and improve my 7.4% of portfolio cost average monthly return. I've made it clear I'm not selling any OPTI:Optibiotix, so my only hopes are the other three. I have stated I'm willing to trade SBTX:SkinBioTherapeutics, but haven't done a very good job of it so far. Although I guess I have made £2,425 profit doing just that, so maybe I shouldn't be too hard on myself.

I'll sell IKA:Ilika relatively soon if they get into profit, as I'm still not convinced at their commercial credentials, and I'm way overweight on JLP:Jubilee Metals given their openly acknowledged aim to grow the company and not return value to shareholders. There's way too much risk of getting fleeced to line the pockets of the Chairman, so although I'll retain a token holding, I'll sell 80% of my shares gradually.

Still above the injection line, but only just. The momentum seems to have ground to a halt.

I was hoping to get the deficit below £10,000 by now, but we're back nearer £20,000.

The SIPP looks like this after week 236

			Weekly Change
Cash	£29.81		-£626.97
Portfolio cost	£52,946.27		+£1,011.06
Portfolio sell value (bid price - commission)	£40,337.17	(-23.8%)	-£1,248.29
Potential profits	£109.04		+£109.04
Yr 5 Dividends	£0		+£0
Yr 5 Interest	£0.03		+£0
Yr 5 Profit from sales	£0		+£0
Yr 5 Average monthly cash profit	-£15.09	(-0.3%)	-£1.99
Total Dividends	£1,899.24		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£12,549.10		+£0
Average monthly cash profit	£255.37	(5.8%)	-£1.38
(Sold stocks profit + Dividends - Fees / Months)
Performance/Injection	8.7%		-0.2%
Compound performance	40%		+0%

This is complicated! I added £400 cash because I wanted to keep the JLP:Jubilee Metals shares while they re-rate, and I could do with the £100 tax rebate to cover future charges. That meant I had £1,000 to be able to buy my next "magic formula" share.

Number 2 on my ranking spreadsheet was APAX:Apax Global Alpha which is a managed fund, and which has been clobbered by the Covid-19 drop, but which hasn't really recovered yet and pays a very healthy dividend. This seemed like a perfect SIPP share, so I bought 695 at 143.7569p costing £1,011.06.

I've decided with the "magic formula" shares I'll buy £1,000 worth not including commission, so most costs will be about £1,011. They haven't really moved since and the bid price is 141.8p, so with spread and commission they are down by £37 (4%).

Meanwhile we have the unprecedented situation of 3 different shares all being in profit this week. FXPO:Ferrexpo is up 6% making £59, JLP:Jubilee Metals is up 5% making £24, and SBTX:SkinBioTherapeutics is up 1% making £24. I'm still planning to sell SBTX:SkinBioTherapeutics when they hit 19.5p as I really need to improve my performance on this account, and most of my  holdings are long term. I want to increase my SBTX holding, and I think the best chance will be to trade them and hope I don't miss the re-rate.

The drop in portfolio value was all down to OPTI:Optibiotix

A complex chart! Injection increased a small amount, cost went up again, and value dropped despite this.

Only a few more weeks until this account will have been in the red for a year.

The trading account looks like this after week 202

			Weekly Change
Cash	£186.37		+£186.28
Portfolio cost	£2,354.11		-£136.10
Portfolio sell value (bid price - commission)	£1,438.10	(-38.9%)	-£19.52
Potential profits	£0		-£65.01
Year 4 Dividends	£13.20		+£0
Year 4 Profit	£320.95		+£200.18
Yr 4 Average monthly cash profit	£31.48	(16%)	+£18.58
Dividends	£47.92		+£0
Profit from sales	£256.66		+£200.18
Average monthly cash profit	£6.53	(3.3%)	+£4.28
(Sold stocks profit + Dividends - Fees  / Months)
Performance/Injection	3.6%		+2.4%
Compound performance	14%		+9%

Quite a lot to pull apart here. I sold JLP:Jubilee Metals at 3.8p after buying at 2.81p and made £200.19 (30.3%) profit. I then removed £150 from the account to reduce the injection amount, and bought 3,361 shares in SBTX:SkinBioTherapeutics at 14.875p costing £511.90, as I believe they are about to go on a sprint to 19.5p.

I saved the excess cash, as I think it was a mistake to pay more than £500 when I bought JLP:Jubilee Metals, as I need some cash buffer in the account to ensure I can afford to sell something at a loss and still have enough to invest £500 with the proceeds.

So although I wiped out my potential profits, my actual profits for the year went up significantly and are now a respectable 16% with only 6 weeks of this trading year to go. My long term performance improved by £4 a month, but is still only 3.3%. However, after the disastrous start, this isn't too bad, and still better than building society interest.

So it means I only really have one holding I can trade with, as the others are losing so much money I'm not prepared to sell them. It means I have to be very, very careful with this one, and only go for shares that are clearly on an upwards trajectory. Easier said than done! I have been learning a lot about trading, so will be using those learnings for future purchases. I didn't really need to with SBTX:SkinBioTherapeutics, as it's clear the recent drop was due to OPTI:Optibiotix dumping 4.5 million shares. Those are already being snapped up, so I think this is a reasonable bet. It means I'll be attempting to trade these in both my trading account and my SIPP. This one will be with the aim of making money, the SIPP one will be with the aim of increasing my holding.

It's been a long time since I was able to further my plan of extracting the whole £2,500 injection from this account. The £150 withdrawn this week has given a welcome dip to the orange line.

So in real terms there was a slight dip, but I did remove £200 profit and £186 is being held in cash, so it's not really a surprise. Most of the portfolio had a good week. It's not often I have felt happy about the trading account.

Last week the virtual magic formula portfolio was down by 15.2%, and this week it's only down by 10.76%, so a 4.44% gain. PLUS:Plus 500 had a bad week, dropping about 10%, but is still the best performer at 44% up. FXPO:Ferrexpo is next best at 31% up, which is nice now I'm a holder. IGG:IG Group are up 13% so also doing quite well. Then BHP:BHP Group, DGOC:Diversified Oil & Gas, KETL:Strix Group, MONY:MoneySupermarket and PSN:Persimmon are all in profit, having recovered form the Coronavirus crash.

Many of them are still dreadful though. CARD:Card Factory is down 45% and VTY:Vistry Group are down 41%, with ITV:ITV down 38% and REDD:Redde Northgate down 30%.

On my newly updated spreadsheet POLR:Polar Capital Holdings were next in line to be bought. They are similar to APAX:Apax Global Alpha in that they are a managed fund, and are still cheap following the crash. They only need to make up 13% to get back where they were before the crash, whereas APAX are still 22% down so were better value. I suspect by the time I get my next pension transfer it will all be different. However, if I can make a quick profit on JLP:Jubilee Metals to get up to £1,000, then I'll be putting it in POLR:Polar Capital Holdings.

So, next week's wish list is a re-rate of JLP:Jubilee Metals, a recovery to 19.5p of SBTX:SkinBioTherapeutics, and some Sweetbiotix news from OPTI:Optibitix that takes us back to 70p...